Litcius/Paper detail

Prophylaxis of Post-Inflammatory Hyperpigmentation From Energy-Based Device Treatments: A Review

Ian T.Y. Wong, Vincent Richer

2020Journal of Cutaneous Medicine and Surgery15 citationsDOI

Abstract

Post-inflammatory hyperpigmentation (PIH) is an acquired hypermelanosis that can result from inflammatory dermatologic disease, trauma, or iatrogenesis from procedures. This condition disproportionately affects individuals with skin of color, and it can place a significant psychosocial burden on affected patients. The management of PIH is, therefore, of great interest to clinicians, especially dermatologists. The treatment of established PIH has long been a principal focus within the literature, with publications on the topic outnumbering publications on prophylaxis of PIH. Prophylaxis strategies to prevent PIH vary greatly in clinical practice, likely due to the absence of an evidence-based consensus. Published approaches to PIH prophylaxis include pretreatment (topical alpha hydroxy acids, retinoids, hydroquinone, and brimonidine) and post-treatment strategies (photoprotection, corticosteroids, and tranexamic acid). This review will examine the current literature on prophylaxis of PIH from energy-based device treatments.

Topics & Concepts

MedicineDermatologyHyperpigmentationTopical agentsIntensive care medicineDermatologic Treatments and ResearchAcne and Rosacea Treatments and EffectsSkin Protection and Aging
Prophylaxis of Post-Inflammatory Hyperpigmentation From Energy-Based Device Treatments: A Review | Litcius